🚀 Limited-time offer€999 for lifetime Pro access - Pay once, own it forever

View offer

GlaxoSmithKline Biologicals

0440.872.918

Normale toestand
  NV
  Founded in 01-07-1990
Profit
€ 1.93B
Increased by 346%
Equity
€ 14.61B
Increased by 12%
Turnover
€ 7.16B
Increased by 46%
Ratio 2022 2021 2020 2019 2018
Credit limit
€ 1.75B
€ 1.56B
€ 2.13B
€ 2.11B
€ 1.88B
Turnover
€ 7.16B
€ 4.92B
€ 6.47B
€ 6.79B
€ 4.69B
Profit
€ 1.93B
€ 431.95M
€ 1.78B
€ 1.99B
€ 515.22M
Equity
€ 14.61B
€ 12.99B
€ 17.72B
€ 17.59B
€ 15.68B
Employees
8,023.70
7,755.70
8,753.30
8,882.50
8,968.30
Dividends
€ 321.93M
€ 81.93M
€ 81.93M
€ 81.93M
€ 81.93M

Directors

Financial statements 12

All financial statements

Publications 138

All publications

Activities according to NACEBEL codes

Locations 5

Relevant companies

Find more

FAQ

Sources

Klaar om te starten?

Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.

App screenshot